A modest amount of money can go a long way in the stock market when it's put to work in time-tested businesses with well-defined competitive advantages.
/CNW/ - On April 17, 2024, the global bleeding disorders community will come together to celebrate World Hemophilia Day. The theme of the event this year is...
Analysts at Goldman Sachs think these 5 underperforming stocks could be poised to outperform, thanks to a healthy valuation discount and expected EPS growth.
Merck's shares are trading in bargain territory. Are they a better growth play than this popular Vanguard fund?
The pharmaceutical giant is laying the groundwork for its next heyday.
The average yield from these stocks is more than five times the market average.
These three stocks are bargains with great dividends.
Is there still too much risk surrounding this business?
These dividend payers have a long history of steady dividend payout raises, and they both offer yields above 6% at recent prices.
When something seems too good to be true it might not be.